Clinical worsening in adult congenital heart disease and heart failure: A single-centre, observational study

Key Points

Heart failure hospitalization and NYHA progression indicate clinical worsening outcomes.
Progression in NYHA class correlates with increased risk for death and advanced heart therapies.

Structured PICO

Are NYHA progression and HF hospitalization markers of clinical worsening related to death, HTX, and VAD implantation in ACHD-HF patients?

Population

Adult congenital heart disease and heart failure (ACHD-HF) patients

Intervention

Current ACHD-HF therapy

Outcome

Death, heart transplantation (HTX), and ventricular assist device (VAD) implantationhard clinical

NYHA progression and HF hospitalization are identified as potential markers of clinical worsening for severe outcomes (death, HTX, VAD) in adult congenital heart disease patients with heart failure.

Abstract

This study characterizes current ACHD-HF therapy and identifies NYHA progression and HF hospitalization as potential markers of clinical worsening as they relate to death, HTX, and VAD implantation.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Bourgeois et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75bf0c6e9836116a242e2 https://doi.org/https://doi.org/10.1016/j.ijcchd.2026.100656

Bookmark

View Full Paper